W7V Overzicht aandelen WELL Health Technologies Corp. opereert als een praktijkgericht bedrijf voor digitale gezondheidszorg in Canada, de Verenigde Staten en internationaal. Meer informatie
Beloningen Risicoanalyse Alle risicocontroles bekijken Leg je gedachten, links en bedrijfsverhaal vast
WELL Health Technologies Corp. Concurrenten Prijsgeschiedenis en prestaties
Overzicht van hoogtepunten, dieptepunten en veranderingen in de aandelenkoersen voor WELL Health Technologies Historische aandelenkoersen Huidige aandelenkoers CA$4.68 52 Week Hoogtepunt CA$4.70 52 Week Laag CA$2.32 Bèta 1.3 1 maand verandering 36.45% 3 maanden verandering 60.29% 1 Jaar Verandering 82.77% 3 jaar verandering 36.02% 5 jaar verandering 345.62% Verandering sinds IPO 3,195.07%
Recent nieuws en updates
WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million. Dec 02
Investor sentiment improves as stock rises 17% Nov 14
New minor risk - Share price stability Nov 13
Third quarter 2024 earnings released: CA$0.33 loss per share (vs CA$0.032 loss in 3Q 2023) Nov 08
WELL Health Technologies Corp. (TSX:WELL) entered into definitive agreement to acquire Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million. Nov 05
WELL Health Technologies Corp. to Report Q3, 2024 Results on Nov 07, 2024 Oct 24 Meer updates bekijken
WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million. Dec 02
Investor sentiment improves as stock rises 17% Nov 14
New minor risk - Share price stability Nov 13
Third quarter 2024 earnings released: CA$0.33 loss per share (vs CA$0.032 loss in 3Q 2023) Nov 08
WELL Health Technologies Corp. (TSX:WELL) entered into definitive agreement to acquire Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million. Nov 05
WELL Health Technologies Corp. to Report Q3, 2024 Results on Nov 07, 2024 Oct 24 Ms. CHAU Hoi Shuen Solina Holly acquired a 7.53% stake in WELL Health Technologies Corp. (TSX:WELL) for CAD 81.01 million. Oct 15
Second quarter 2024 earnings released: EPS: CA$0.45 (vs CA$0.024 loss in 2Q 2023) Aug 15
WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024 Aug 15
WELL Health Technologies Corp. to Report Q2, 2024 Results on Aug 14, 2024 Jul 30
Investor sentiment improves as stock rises 16% Jun 27
New major risk - Revenue and earnings growth Jun 20
WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024 May 09
First quarter 2024 earnings released: EPS: CA$0.062 (vs CA$0.062 loss in 1Q 2023) May 08
WELL Health Technologies Corp. to Report Q1, 2024 Results on May 08, 2024 May 08
WELL Health Technologies Corp., Annual General Meeting, Jun 12, 2024 Apr 03
Well Health Technologies Corp. Raises Earnings Guidance for 2024 Mar 23
Full year 2023 earnings released: EPS: CA$0 (vs CA$0.006 in FY 2022) Mar 22
WELL Health Technologies Corp. to Report Q4, 2023 Results on Mar 21, 2024 Mar 19
WELL Health Technologies Corp. Announces the Creation of A Dedicated Public Sector Group to Help Tech Enable Public Health Systems Operating At Scale Feb 08 Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million. Feb 02
Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million. Jan 26 WELL Health Technologies Corp. announced that it has received CAD 0.074876 million in funding Dec 08
Well Health Announces Launch of Well Ai Inbox Admin: A Revolutionary Ai-Powered Solution for Clinic Inbox Management Nov 22
New minor risk - Share price stability Nov 17
Third quarter 2023 earnings released: CA$0.032 loss per share (vs CA$0.019 loss in 3Q 2022) Nov 17
Well Health Technologies Corp. Provides Earnings Guidance for the Year 2023 and 2024 Nov 17
WELL Health Technologies Corp. Launches WELL Longevity+ Program Nov 10
WELL Health Technologies Corp. to Report Q3, 2023 Results on Nov 14, 2023 Nov 08
Independent Director recently sold €112k worth of stock Oct 16
WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Clinic assets from MCI Medical Clinics Inc. Oct 05
Second quarter 2023 earnings released: CA$0.024 loss per share (vs CA$0.027 loss in 2Q 2022) Aug 11
WELL Health Technologies Corp. to Report Q2, 2023 Results on Aug 10, 2023 Aug 04
WELL Health Technologies Corp. (TSX:WELL) entered into an agreement to acquire Significant Portion of Clinical Assets of MCI Medical clinics Inc. Jul 22
Well Health Technologies Corp. Provides Revenue Guidance for the Year 2023 Jul 14
WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR). Jun 02
WELL Health Technologies Corp. (TSX:WELL) entered into a definitive share purchase agreement to acquire MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR) for CAD 2 million. May 20
First quarter 2023 earnings released: CA$0.062 loss per share (vs CA$0.038 loss in 1Q 2022) May 14
WELL Health Technologies Corp. Provides Earnings Guidance for the Year 2023 May 13
WELL Health Technologies Corp. Announces the Launch of Its Ground-Breaking Product, WELL AI Voice May 11
WELL Health Technologies Corp. to Report Q1, 2023 Results on May 12, 2023 May 06
Full year 2022 earnings released: EPS: CA$0.006 (vs CA$0.23 loss in FY 2021) Mar 22
Forecast to breakeven in 2024 Nov 16
Forecast to breakeven in 2024 Nov 12
Third quarter 2022 earnings released: CA$0.019 loss per share (vs CA$0.061 loss in 3Q 2021) Nov 11
WELL Health Technologies Corp. Increases Annual Revenue Guidance for 2022 Nov 11 WELL Health Technologies Corp. to Report Q3, 2022 Results on Nov 10, 2022
Independent Director recently sold €267k worth of stock Oct 15
WELL Health Technologies Corp. (TSX:WELL) entered into an agreement to acquire Cloud Practice Inc. and 3 Clinics from CloudMD Software & Services Inc. (TSXV:DOC) for CAD 5.75 million. Oct 12
Independent Director recently sold €116k worth of stock Oct 06
Second quarter 2022 earnings released: CA$0.027 loss per share (vs CA$0.08 loss in 2Q 2021) Aug 13
WELL Health Technologies Corp. Updates Revenue Guidance for the Year of 2022 Aug 12 WELL Health Technologies Corp. Announces Appointment of Sybil Lau to its Board of Directors
WELL Health Technologies Corp. Provides Revenue Guidance for the Second Quarter 2022 Jul 22
WELL Appoints Iain Paterson to the Position of Chief Information Security Officer Jul 09
WELL Health Technologies Corp. (TSX:WELL) entered into an asset purchase agreement to acquire Assets of INLIV Inc. from Coril Holdings Ltd. for CAD 1.8 million. Jun 22
No longer forecast to breakeven May 20 WELL Health Technologies Corp. has completed a Follow-on Equity Offering in the amount of $30.01107 million. May 20
First quarter 2022 earnings released: CA$0.038 loss per share (vs CA$0.046 loss in 1Q 2021) May 13
WELL Health Technologies Corp. Revises Earnings Guidance for the Year 2022 May 12
WELL Health Technologies Corp. to Report Q1, 2022 Results on May 12, 2022 May 07
Forecast breakeven date moved forward to 2022 Apr 27
WELL Health Technologies Corp. Provides Preliminary Earning Guidance for the First Quarter Ended March 31, 2022 Apr 26
WELL Health Technologies Corp., Annual General Meeting, Jun 17, 2022 Apr 14
Full year 2021 earnings released: CA$0.23 loss per share (vs CA$0.028 loss in FY 2020) Apr 03
WELL Health Technologies Corp. Provides Earnings Guidance for the Year 2022 Apr 01
WELL Health Technologies Corp. (TSX:WELL) acquired CognisantMD for CAD 24.57 million. Dec 03
Forecast to breakeven in 2023 Nov 27
No longer forecast to breakeven Nov 24
Third quarter 2021 earnings released: CA$0.061 loss per share (vs CA$0.027 loss in 3Q 2020) Nov 11
Forecast to breakeven in 2022 Sep 23
WELL Health Technologies Corp. (TSX:WELL) entered into a definitive stock purchase agreement to acquire a 53% stake in WISP, Inc. for $41.3 million. Sep 04
No longer forecast to breakeven Aug 14
Second quarter 2021 earnings released: CA$0.083 loss per share (vs CA$0.027 loss in 2Q 2020) Aug 14
WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MyHealth Partners Inc. Jul 16
WELL Health Technologies Corp. (TSX:WELL) agreed to acquire MyHealth Partners Inc. for approximately CAD 270 million. Jun 09
Forecast breakeven moved forward to 2021 Jun 08
WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of 51% stake in Doctors Services Group Limited. Jun 03
First quarter 2021 earnings released: CA$0.043 loss per share (vs CA$0.017 loss in 1Q 2020) May 12
WELL Health Technologies Corp. Offers Health Records on Iphone to Empower Patient Engagement May 06
WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of ExecHealth Inc. May 04
WELL Health Technologies Corp. (TSX:WELL) signed a definitive share purchase agreement to acquire a 51% stake in Doctors Services Group Limited for CAD 1.4 million. May 01
Full year 2020 earnings released: CA$0.024 loss per share (vs CA$0.081 loss in FY 2019) Mar 19
WELL Health Technologies Corp. to Report Q4, 2020 Results on Mar 18, 2021 Mar 18
WELL Health Technologies Corp. Announces Executive Changes Mar 16
WELL Health Technologies Corp. (TSX:WELL) entered into a share purchase agreement to acquire Intrahealth Systems Limited for $19.3 million. Mar 10
WELL Health Technologies Corp. (TSX:WELL) signed a definitive agreement to acquire CRH Medical Corporation (TSX:CRH) for approximately $300 million. Feb 10
WELL Health Technologies Corp. (TSX:WELL) acquired Open Health Software Solutions Inc. Jan 09
WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Adracare Inc. Jan 05
Independent Director recently sold €65k worth of stock Jan 01 Rendement voor aandeelhouders W7V DE Healthcare DE Markt 7D 5.5% -3.5% -2.6% 1Y 82.8% 15.6% 6.9%
Bekijk het volledige aandeelhoudersrendement
Rendement versus industrie: W7V overtrof de German Healthcare industrie, die het afgelopen jaar een rendement 15.6 % opleverde.
Rendement versus markt: W7V overtrof de German markt, die het afgelopen jaar een rendement opleverde van 6.9 %.
Prijsvolatiliteit Is W7V's price volatile compared to industry and market? W7V volatility W7V Average Weekly Movement 7.7% Healthcare Industry Average Movement 4.7% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.2% 10% least volatile stocks in DE Market 2.4%
Stabiele aandelenkoers: De aandelenkoers van W7V is de afgelopen 3 maanden volatiel geweest.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 8% ) van W7V is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen German.
Over het bedrijf Opgericht Werknemers CEO Website 2010 n/a Hamed Shahbazi well.company
WELL Health Technologies Corp. opereert als een op zorgverleners gericht digitaal gezondheidszorgbedrijf in Canada, de Verenigde Staten en internationaal. Het bedrijf biedt omnichannel patiëntendiensten en -oplossingen voor specifieke markten, zoals personeel voor zorgverleners, anesthesie, gastro-intestinale gezondheid, vrouwengeneeskunde, eerstelijnsgezondheidszorg en geestelijke gezondheidszorg. Het bedrijf ontwikkelt, integreert en verkoopt ook zijn eigen suite van technologische software en technologische oplossingen voor medische klinieken en zorgverleners.
Meer tonen WELL Health Technologies Corp. Samenvatting Hoe verhouden de winst en inkomsten van WELL Health Technologies zich tot de beurswaarde? W7V fundamentele statistieken Marktkapitalisatie €1.18b Inkomsten(TTM ) €48.97m Inkomsten(TTM ) €638.71m
24.1x Koers/Winstverhouding Inkomsten en omzet Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM) W7V resultatenrekening (TTM ) Inkomsten CA$957.69m Kosten van inkomsten CA$534.80m Brutowinst CA$422.89m Overige uitgaven CA$349.47m Inkomsten CA$73.43m
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
n.v.t.
Winst per aandeel (EPS) 0.29 Brutomarge 44.16% Nettowinstmarge 7.67% Schuld/Eigen Vermogen Verhouding 34.9%
Hoe presteerde W7V op de lange termijn?
Bekijk historische prestaties en vergelijking
Bedrijfsanalyse en status van financiële gegevens Gegevens Laatst bijgewerkt (UTC-tijd) Bedrijfsanalyse 2024/12/22 21:58 Aandelenkoers aan het einde van de dag 2024/12/20 00:00 Inkomsten 2024/09/30 Jaarlijkse inkomsten 2023/12/31
Gegevensbronnen De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC . De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
Pakket Gegevens Tijdframe Voorbeeld Amerikaanse bron * Financiële gegevens bedrijf 10 jaar Resultatenrekening Kasstroomoverzicht Balans Consensus schattingen analisten +3 jaar Financiële prognoses Koersdoelen analisten Marktprijzen 30 jaar Aandelenprijzen Dividenden, splitsingen en acties Eigendom 10 jaar Top aandeelhouders Handel met voorkennis Beheer 10 jaar Leiderschapsteam Raad van bestuur Belangrijkste ontwikkelingen 10 jaar
* voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige regelgevingsformulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Lees hier meer.
Analysemodel en Snowflake Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina . We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube .
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op .
Bronnen van analisten WELL Health Technologies Corp. wordt gevolgd door 25 analisten. 15 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
Analist Instelling Gabriel Leung Beacon Securities Limited Douglas Taylor Canaccord Genuity Scott Fletcher CIBC Capital Markets
Toon 22 meer analisten 
